Coverage
-
May 14, 2014
A Washington, D.C., federal judge on Wednesday threw out Teva Pharmaceutical Industries Ltd.'s lawsuit seeking to prevent the U.S. Food and Drug Administration from approving generic versions of Teva's multiple sclerosis drug Copaxone without requiring additional clinical data, saying the case is "premature and ill-considered."
2 other articles on this case.
View all »